Overview
The Cortellis Competitive Intelligence MCP connector gives AI assistants structured access to global biopharma intelligence for competitive analysis, asset tracking, and research workflows. It helps teams move from a natural-language question to evidence-led answers grounded in Cortellis Competitive Intelligence data, without leaving the AI environment where they plan, analyze, and communicate. The connector supports research across the full drug-development lifecycle, from early research through commercialization. Users can investigate drugs, companies, therapeutic areas, clinical trials, patents, regulatory activity, deals, news, and market signals; then bring the relevant findings into product strategy, business-development, portfolio, medical-affairs, and competitive-intelligence workflows. Cortellis Competitive Intelligence is built from sources that matter most for biopharma analysis: press releases, seven major global patent offices, ClinicalTrials.gov and other trial sources, company pipelines and presentations, 100+ scientific and medical conferences, annual reports, SEC filings, broker research, major regulatory agencies including FDA, EMA, PMDA, and TGA, and 700+ peer-reviewed journals.
